Clinician's Roundtable

Host: Leslie P. Lundt, MD

Guest: Steven Brown, MD

Dr. Brown discusses the single most important intervention for patients showing warning signs and/or developing manifestations of pulmonary disease: quitting smoking.

Host: Leslie P. Lundt, MD

Guest: Steven Brown, MD

In this segment, Dr. Brown examines the diagnostic fundamentals of COPD and the most accurate methodologies used to diagnose this pulmonary disease.

Host: Cathleen Margolin, PhD

Guest: G. Terence Wilson, PhD

Dr. G. Terence Wilson discusses the controversy about manual-based psychological treatments as a model for research and practice.

Host: Cathleen Margolin, PhD

Guest: G. Terence Wilson, PhD

Dr. G. Terence Wilson examines Eating Disorder Not Otherwise Specified, the most common eating disorder encountered by health care professionals.

Host: Cathleen Margolin, PhD

Guest: G. Terence Wilson, PhD

Dr. G. Terence Wilson talks about the most effective therapies for bulimia nervosa.

Host: Cathleen Margolin, PhD

Guest: G. Terence Wilson, PhD

Dr. G. Terence Wilson discusses the complications of treating anorexia nervosa.

Host: Larry Kaskel, MD

Guest: James Bream, JD

Every doctor gets asked at one time or another to give medical advice to a family member or friend. Dr. Larry Kaskel puts attorney Jim Bream to the test to find a way out of a potentially sticky situation.

Host: Larry Kaskel, MD

Guest: James Bream, JD

Attorney, Jim Bream joins Dr. Kaskel to discuss the very real effects of Medical Malpractice Stress Syndrome and what do about it, as well as concrete steps doctors should take if they are sued.

Host: Larry Kaskel, MD

Guest: James Bream, JD

Learn about the myths regarding medical malpractice when attorney Jim Bream joins Dr. Kaskel for another lively discussion.

Host: Larry Kaskel, MD

Guest: Sandeep Vijan, PhD

What are the economic implications of the study on cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease? Recent clinical trials found that high-dose statin therapy, compared with conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with acute coronary syndromes (ACS) and stable coronary artery disease (CAD). What does this mean for the business of medicine? Have we established what one day of life is worth, and how do we know when to pay the price?